Divi's Laboratories Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Unit-2, Chippada Village, Annavaram Post Bheemunipatnam Mandal, Visakhapatnam District, Andhra Pradesh 531162, India (IND)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3004149463 · DUNS 676446492
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-07-19
- NAIDrug Quality Assurance2020-01-31
- VAIDrug Quality Assurance2017-09-19
- OAIDrug Quality Assurance2016-12-06
- NAIDrug Quality Assurance2016-02-19
- VAIDrug Quality Assurance2014-06-06
- VAIDrug Quality Assurance2012-07-19
- VAIDrug Quality Assurance2009-04-09
Drugs this plant is listed as making
2 distinct drugs across 3 products name this site in their FDA label.
- bosentanActelion Pharmaceuticals US, Inc.
- Sumatriptan Succinate and Naproxen SodiumCurrax Pharmaceuticals LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.